Literature DB >> 29761253

Endoscopic Interventions in the Treatment of Obesity and Diabetes.

A Ruban1, A Uthayakumar2, H Ashrafian3, J P Teare3.   

Abstract

Obesity is a global health problem which is on the rise and is strongly associated with the development of type 2 diabetes and other comorbidities. Bariatric surgery is now an established treatment for both these conditions, leading to impressive results in weight loss and glycemic control. More recently, we have seen the development of various endoscopic devices as potential alternatives or adjuncts to bariatric surgery. In this state-of-the-art review, we outline the current landscape of endoscopic treatments available for the management of both obesity and diabetes, including the clinical evidence supporting their use, efficacy, safety, and potential mechanisms of action.

Entities:  

Keywords:  Bariatrics; Diabetes; Endoscopy; Obesity

Mesh:

Year:  2018        PMID: 29761253     DOI: 10.1007/s10620-018-5117-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  70 in total

1.  Nutrient infusion bypassing duodenum-jejunum improves insulin sensitivity in glucose-tolerant and diabetic obese subjects.

Authors:  Serenella Salinari; Richard D Carr; Caterina Guidone; Alessandro Bertuzzi; Stefania Cercone; Maria E Riccioni; Andrea Manto; Giovanni Ghirlanda; Geltrude Mingrone
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-07       Impact factor: 4.310

2.  Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve.

Authors:  Bryan J Sandler; Roberto Rumbaut; C Paul Swain; Gustavo Torres; Luis Morales; Lizcelly Gonzales; Sarah Schultz; Mark Talamini; Santiago Horgan
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

3.  An intragastric balloon produces large weight losses in the absence of a change in ghrelin or peptide YY.

Authors:  N R Fuller; N S Lau; G Denyer; I D Caterson
Journal:  Clin Obes       Date:  2013-08-23

4.  Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.

Authors:  Michael J Theodorakis; Olga Carlson; Spyros Michopoulos; Máire E Doyle; Magdalena Juhaszova; Kalliopi Petraki; Josephine M Egan
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-10-11       Impact factor: 4.310

Review 5.  The Impact of Intragastric Balloons on Obesity-Related Co-Morbidities: A Systematic Review and Meta-Analysis.

Authors:  Violeta B Popov; Amy Ou; Allison R Schulman; Christopher C Thompson
Journal:  Am J Gastroenterol       Date:  2017-01-24       Impact factor: 10.864

6.  Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up.

Authors:  Gontrand Lopez-Nava; Reem Z Sharaiha; Eric J Vargas; Fateh Bazerbachi; Galvao Neto Manoel; Inmaculada Bautista-Castaño; Andres Acosta; Mark D Topazian; Manpreet S Mundi; Nikhil Kumta; Michel Kahaleh; Andrea Marie Herr; Alpana Shukla; Louis Aronne; Christopher J Gostout; Barham K Abu Dayyeh
Journal:  Obes Surg       Date:  2017-10       Impact factor: 4.129

7.  Effects of duodenal fat, protein or mixed-nutrient infusions on epigastric sensations during sustained gastric distension in healthy humans.

Authors:  C Feinle; M Christen; D Grundy; H Faas; O Meier; B Otto; M Fried
Journal:  Neurogastroenterol Motil       Date:  2002-04       Impact factor: 3.598

8.  Gastrointestinal Physiological Changes and Their Relationship to Weight Loss Following the POSE Procedure.

Authors:  J C Espinós; R Turró; G Moragas; A Bronstone; J N Buchwald; F Mearin; A Mata; H Uchima; J Turró; S Delgado-Aros
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

Review 9.  ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies.

Authors:  Barham K Abu Dayyeh; Nitin Kumar; Steven A Edmundowicz; Sreenivasa Jonnalagadda; Michael Larsen; Shelby Sullivan; Christopher C Thompson; Subhas Banerjee
Journal:  Gastrointest Endosc       Date:  2015-07-29       Impact factor: 9.427

10.  Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis.

Authors:  Nicola Crea; Giacomo Pata; Domenico Della Casa; Luigi Minelli; Giovanni Maifredi; Ernesto Di Betta; Francesco Mittempergher
Journal:  Obes Surg       Date:  2009-06-09       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.